- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04818190
DIEP (Deep Inferior Epigastric Artery Perforator) Flap Sensory Recovery Following Neurotization
DIEP Flap Sensory Recovery Following Direct Neurotization in Breast Reconstruction - A Blinded Prospective Study
The purpose of this study is to compare the sensory return of DIEP flaps with nerve connection to DIEP flaps with no nerve connection to see which is better.
This research is being done because the presence of sensation in a reconstructed breast has been shown to improve patient-related quality of life following mastectomy reconstruction and is an important safety factor for prevention of burns and other flap injuries. Unfortunately, women who have breast skin excised during mastectomy are reconstructed with a traditional DIEP flap that does not restore sensation to the skin.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Deep Inferior Epigastric Perforator (DIEP) flap is the current standard of care in breast reconstruction. The DIEP flap does not normally have sensation restored. The presence of sensation in a reconstructed breast has been shown to improve patient-rated quality of life following mastectomy and reconstruction and is an important safety factor for prevention of burns and other flap injuries. Unfortunately, women who have breast skin excised during mastectomy are reconstructed with a traditional DIEP flap that does not restore sensation to the skin. As such, the investigators aim to perform a prospective randomized single-blinded trial to evaluate sensory return to DIEP flaps following nerve coaptation.
A blinded, prospective study will be performed involving Manitoban women over 18 years undergoing bilateral breast reconstruction with DIEP flaps. The women will have one breast reconstructed in the standard of care (DIEP flap with no nerve coaptation) and one breast reconstructed with both DIEP flap and sensory nerve coaptation; the side of coaptation will be randomized. Objective sensibility to the breast will be tested pre- and post-operatively (3, 6, 12 months) using the Pressure Specified Sensory Device (PSSD). Patients will also complete the Breast Q questionnaire postoperatively.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3A 1R9
- Health Science Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- female subjects older than 18
- scheduled for immediate bilateral breast reconstruction following bilateral non-nipple sparing mastectomy
- using DIEP free flap reconstruction
- with a large skin paddle
Exclusion Criteria:
- pre-operative radiation or chemotherapy was performed
- post-operative radiation or chemotherapy is planned
- reconstruction is performed in a delayed fashion
- a nerve conduit is necessary for nerve coaptation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: DIEP reconstruction, no neurotization
DIEP reconstruction No sensory neurotization
|
|
|
Experimental: DIEP reconstruction, neurotization
DIEP reconstruction With sensory neurotization
|
The donor nerve is a cutaneous nerve that is identified with the most inferior lateral perforator vessels.
The nerve is then dissected for neurotization and divided at the level of the fascia where it is a pure sensory nerve.
The recipient intercostal nerve is usually easily identified in the third intercostal space during the dissection of the internal mammary artery and vein.
The anterior branch of the third intercostal nerve can usually be found at the junction of the inferior portion of the third rib and the sternum, approximately 80% of the time.
The nerve is dissected and transected medially.
It is then mobilized to give it the longest length possible in preparation for neurotization.
Neurotization is performed by coapting the donor nerve to the third anterior intercostal nerve directly with a 9-0 nylon suture in standard fashion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensory recovery to neurotized DIEP flap
Time Frame: 3 months post-operatively
|
Sensory recovery measured using Pressure Specified Sensory Device
|
3 months post-operatively
|
|
Sensory recovery to neurotized DIEP flap
Time Frame: 6 months post-operatively
|
Sensory recovery measured using Pressure Specified Sensory Device
|
6 months post-operatively
|
|
Sensory recovery to neurotized DIEP flap
Time Frame: 12 months post-operatively
|
Sensory recovery measured using Pressure Specified Sensory Device
|
12 months post-operatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rebecca Miller, MD, University of Manitoba
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HS24687
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sensitisation
-
Amazentis SAPrinceton Consumer ResearchRecruitingIrritation/Irritant | SensitisationUnited Kingdom
-
Amazentis SAPrinceton Research CorporationCompletedIrritation/Irritant | SensitisationUnited Kingdom
-
Covalon Technologies Inc.ALS Beauty and Personal CareCompleted
-
Amazentis SAPrinceton Research CorporationCompletedIrritation/Irritant | SensitisationUnited Kingdom
-
Toronto Rehabilitation InstituteCompleted
-
University Hospital, GrenobleBristol-Myers SquibbTerminatedSensitisation | Highly Sensitised Dialysis PatientsFrance
-
Kley Hertz S/AUnknown
-
Amazentis SAPrinceton Consumer ResearchCompletedIrritation/Irritant | SensitisationUnited Kingdom
-
PT. Medisafe TechnologiesCompleted
-
Central Medicare Sdn. Bhd.Consumer Product Testing Company, Inc.Completed
Clinical Trials on Sensory neurotization
-
Maastricht University Medical CenterCompleted
-
Maastricht University Medical CenterCompleted
-
Maastricht University Medical CenterCompleted
-
Johns Hopkins UniversityAxogen CorporationTerminatedBreast Cancer | Breast Reconstruction | Sensory RestorationUnited States
-
Chang Gung Memorial HospitalActive, not recruitingBreast Reconstruction | Breast Cancer Patients | Nipple-sparing MastectomyTaiwan
-
Stanford UniversityTerminatedNeurotrophic Keratitis | Neurotrophic Corneal Ulcer | Cranial Nerve V DiseasesUnited States
-
University Hospital, Strasbourg, FranceTerminated
-
Fakultas Kedokteran Universitas IndonesiaNot yet recruitingMastectomy and Breast Reconstruction | Breast Reconstruction After Mastectomy | Neurotization | Quality of Life (QOL) | Peripheral Nerve Regeneration | Sensory FunctionIndonesia
-
University of Wisconsin, MadisonWithdrawnBreast Reconstruction | Neurotization
-
Assiut UniversityNot yet recruitingNerve Transfer